Ansell (ASX:ANN) Shares Climb On Margin Gains And Strong FY27 Outlook

The market came into today already leaning in Ansell’s favour. The stock closed at A$38.24, capping a 7‑day gain of about 9% and a 3‑month climb of about 43%. That is a strong setup for any earnings test.

The headline this time is profit quality. Ansell delivered adjusted earnings per share of about US$1.49 for FY26 and lifted its adjusted operating margin to 15%. Management is guiding to higher adjusted earnings again in FY27. The immediate price reaction tells you what traders think. The margin story and earnings guidance will matter more for long term holders.

Is Ansell a genuine bargain at a 37.3% discount to the stated fair value, or is the lower P/E simply reflecting slower growth forecasts? See how the current price lines up in our valuation analysis for Ansell.

FY 2026 Earnings Summary

• Revenue (FY 2026 vs FY 2025 PCP): US$2,140.2 million vs US$2,003.3 million (higher year on year)
• Net Income (Excl. Extra Items, FY 2026 vs FY 2025 PCP): US$208.6 million vs US$101.6 million (higher year on year)
• Basic EPS (FY 2026 vs FY 2025 PCP): US$1.46 vs US$0.70 (higher year on year)
• Operating Margin (FY 2026 vs FY 2025 PCP): 15.0% vs 14.1% (improved margin performance)

Prefer clear charts over another wall of earnings tables and margin figures? See Ansell’s full financial picture with a visual breakdown of its valuation story in the company report for Ansell.

Ansell bull case: margin, mix and cash milestones

Bulls argue that Ansell is a steady compounder that can pair structural PPE demand with ongoing margin improvement and tight cost control. FY26 goes some way to backing that up. Adjusted net sales grew 5.7%, with H2 accelerating to 9.2%, which supports the claim of healthier organic momentum rather than a one off rebound. EBIT margin reached 15% and Healthcare margin moved from 12.8% to 14.3%, which is consistent with the story that APIP savings and portfolio mix are lifting profitability. Cash conversion at 113% and lower net debt to EBITDA of 1.3x show that earnings are turning into cash and strengthening the balance sheet. Cleanroom and Scientific growth of about 10% for the year, and about 17% in H2, supports the narrative that higher value niches and the Kimberly Clark PPE integration are contributing.

Ansell bear case: testing resilience and execution risks

The bear case has focused on input cost shocks, integration risk and the possibility that recent gains are fragile. FY26 results still show exposure to these themes rather than closing the book on them. Management highlighted U.S. tariff changes and Middle East disruption as material factors, and pricing actions in late FY26 imply that part of the margin story depends on the timing of pass through rather than only on structural efficiency. Competition intensified during supply disruption, which challenges the idea that premium positioning fully shields Ansell on pricing. Execution risk remains live as ERP rollout and further supply chain consolidation are multi year tasks. Guidance for FY27 adjusted EPS of US$1.58 to US$1.70 assumes continued pricing flexibility and portfolio shift to higher value products, so any slip in project delivery or cost management would directly test that confidence.

Access the analyst estimates for Ansell to see where the consensus models start to diverge on Ansell’s multi year earnings path and to find when the street quietly marks the next potential inflection point.

Stay Ahead With Simply Wall St

If Ansell’s margin progress and the current discount to stated fair value have your attention, register for free with Simply Wall St and add it to your Watchlist to track the share price against fair value and watch how new earnings updates feed into the story. Once you have taken a position, keep your focus with the Portfolio Command Center that surfaces only the most important developments for your holdings. Round this out by using the Community to see how other investors are thinking about the same risks and opportunities. This combination helps you spot hidden catalysts and potential risks earlier so you can stay a step ahead of the market.

Seeking Alternatives Beyond Ansell Today

Fresh stock ideas can move from quiet accumulation to full breakout quickly. Consider identifying new momentum opportunities while they are still under the radar.

• Scan for income opportunities that aim to keep paying even when sentiment cools by reviewing a curated set of high yield candidates in the 5 dividend fortresses.
• Target companies where balance sheets and fundamentals look robust before the crowd fully catches on by using the carefully filtered list of solid balance sheet and fundamentals stocks (21 results).
• Hunt for potential future leaders still flying below most radars through a focused collection of quality small and mid caps in the 9 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com